Former Moderna scientist: “It’s a case of the emperor’s new clothes. They’re running an investment firm, and then hopefully it also develops a drug that’s successful.”

I’m just going to go ahead and paste here from wiki about the ten year history of failure, failure, and nothing but failure from Moderna. It looks more like a money-laundering outfit than anything else. So ask yourself, how is it that after ten years of producing nothing, they were able to come up with a highly safe and highly effective Corona vaxx to enter into human trials just five WEEKS.

At the very end, you will read about the promise they made to Trump, and you will understand a great many things:

In 2010, ModeRNA Therapeutics was formed to commercialize the research of stem cell biologist Derrick Rossi. Rossi had developed a method of modifying mRNA by first transfecting it into human cells, then dedifferentiating it into bone marrow stem cells which could then be further differentiated into desired target cell types.[22][23] Rossi approached fellow Harvard University faculty member Tim Springer, who solicited co-investment from Kenneth R. ChienBob Langer, and venture capital firm Flagship Ventures.[23][24] Together they founded a company named from the combined terms “modified” and “RNA”.[25]

In 2011, the CEO of Flagship Ventures (now Flagship Pioneering), Noubar Afeyan, brought in European pharma sales and operations executive Stéphane Bancel as CEO.[23][11] Afeyan personally owned 19.5% of Moderna and was the largest single shareholder, while his fund, Flagship Pioneering, owned 18%.[26]

In March 2013, Moderna and AstraZeneca signed a five-year exclusive option agreement to discover, develop, and commercialize mRNA for treatments in the therapeutic areas of cardiovascular, metabolic, and renal diseases, and selected targets for cancer.[11][27][28] The agreement included a $240 million upfront payment to Moderna, a payment which was “one of the largest ever initial payments in a pharmaceutical industry licensing deal that does not involve a drug already being tested in clinical trials”,[27] and an eight percent share in Moderna.[26] As of May 2020, only one candidate has passed Phase I trials, a treatment for myocardial ischemia, labelled AZD8601.[a][30]

In 2013, Rossi, Chien and their team reported that they were able to improve heart function in mice and enhance their long-term survival with a “redirection of their [stem cell] differentiation toward cardiovascular cell types” in a significant step towards regenerative therapeutics for Moderna.[31][32] In the same year and on the strength of the Nature Biotechnology paper, Moderna received from other investors $110 million.[31]

In January 2014, Moderna and Alexion Pharmaceuticals entered a $125 million deal for orphan diseases in need of therapies. Alexion paid Moderna $100 million for ten product options to develop rare-disease treatments, including for Crigler-Najjar syndrome, using Moderna’s mRNA therapeutics platform.[33] By 2016, Bancel told an audience of JPMorgan Chase investors that the work with Alexion would shortly enter human trials. However, by 2017, the program with Alexion had been scrapped as the animal trials showed that Moderna’s treatment would never be safe enough for humans.[11][12]

In February 2016, a Nature editorial criticized Moderna for not publishing any peer-reviewed papers on its technology, unlike most other emerging and established biotech companies, and compared its approach to that of the controversially failed Theranos.[34] In September 2018, Thrillist published an article titled, “Why This Secretive Tech Start-Up Could Be The Next Theranos”,[35] criticizing its reputation for secrecy and the absence of scientific validation or independent peer-review of its research, though having the highest valuation of any U.S. private biotech company at more than $5 billion.[11][36] A former Moderna scientist told Stat: “It’s a case of the emperor’s new clothes. They’re running an investment firm, and then hopefully it also develops a drug that’s successful.”[11]

In 2018, the company rebranded as “Moderna Inc.” with the ticker symbol MRNA, and further increased its portfolio of vaccine development.[10] In December 2018, Moderna became the largest biotech initial public offering in history, raising $621 million (27 million shares at $23 per share) on NASDAQ, and implying an overall valuation of $7.5 billion for the entire company.[37][38] The year-end 2019 SEC filings showed that Moderna had accumulated losses of $1.5 billion since inception, with a loss of $514 million in 2019 alone, and had raised $3.2 billion in equity since 2010.[10][26]

In March 2020, in a White House meeting between the Trump administration and pharmaceutical executives, Bancel told the president Moderna could have a COVID-19 vaccine ready in a few months.[10] The next day, the FDA approved clinical trials for the Moderna vaccine candidate, with Moderna later receiving investment of $483 million from Operation Warp Speed.[10] Moderna board member, Moncef Slaoui, was appointed head scientist for the Operation Warp Speed project.[10]

8 thoughts on “Former Moderna scientist: “It’s a case of the emperor’s new clothes. They’re running an investment firm, and then hopefully it also develops a drug that’s successful.””

  1. I had this realization regarding professional science over a decade ago. I worked for a company that was a decade into the “startup” phase, sold no products, and it’s first “profitable” year was getting a large payment from a partnership. By the time I had left they still had no product on the market.

    Most of these tech and biotech companies are glorified scholarship applicants whose dream is to sell to bigger firms driven by the usury economy.

  2. Amazing Polly over on BitChute (she’s been banned from YouTube from the covid jihadists) has a 30 minute video about how corrupt the medical journals have become. Once upon a time, medical journals could have shut down Moderna with just one peer-reviewed article. It’s disturbing to hear that peer-reviewed journals have become dishonest but not surprising. All of this mess maps back up to Bill and Melinda Gates. The amount of power those two and their B.S. foundation have is shocking. We are truly living under an oligarch dictatorship. Here’s the link to Polly’s video:

  3. We have enjoyed great medicine in America for as long as we have been a nation. But personal experience with Covid has taught us some dismaying things. Doctors are not giving their own patients recommendations for protocols if they get Covid, indeed, you can’t even get in to see your doctor. You can’t get past the secretaries. Why have doctors all pulled back and don’t mention Vit D3, Vit C, Zinc, Quercetin, Ivermectin, etc.? Doctors look and act AFRAID.

  4. So here’s the truth. Moderna was a failure. Nothing it did worked. In 2017 they were going to turn to vaccines. From Stat NEWS in 2017. “It’s all vaccines right now, and vaccines are a loss-leader,” said one former Moderna manager. “Moderna right now is a multibillion-dollar vaccines company, and I don’t see how that holds up.”

    Here’s how it holds up: create a worldwide pandemic and offer your failed RNA technology as the solution! Get other companies to compete with the same failed tech. Create a consensus that way. Everyone wins. And damn the millions of lives lost!

    Why did “warp speed” work? Because all these mRNA vaccines were already there, ready to be injected somewhere because they failed everywhere else.

    Moderna and the rest of BiG Pharma know these vaccines won’t work. And they don’t care. They don’t have to care: they have immunity. They will get the money, and humanity suffers.

    You had poison injected into your arms.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.